Review



fluorogenic peptide substrate iii  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems fluorogenic peptide substrate iii
    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the <t>fluorogenic</t> peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least <t>three</t> independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 59 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic peptide substrate iii/product/R&D Systems
    Average 94 stars, based on 59 article reviews
    fluorogenic peptide substrate iii - by Bioz Stars, 2026-05
    94/100 stars

    Images

    1) Product Images from "2′-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood"

    Article Title: 2′-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood

    Journal: iScience

    doi: 10.1016/j.isci.2025.114308

    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the fluorogenic peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least three independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Figure Legend Snippet: 2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the fluorogenic peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least three independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.

    Techniques Used: Membrane, Western Blot, Control, Cell Culture, Enzyme-linked Immunosorbent Assay, Incubation, Fluorescence



    Similar Products

    fluorogenic peptide substrate iii  (R&D Systems)
    94
    R&D Systems fluorogenic peptide substrate iii
    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the <t>fluorogenic</t> peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least <t>three</t> independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic peptide substrate iii/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    fluorogenic peptide substrate iii - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    mca p l a q a v dpa r s s s r nh2 fluorogenic peptide substrate iii  (R&D Systems)
    94
    R&D Systems mca p l a q a v dpa r s s s r nh2 fluorogenic peptide substrate iii
    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the <t>fluorogenic</t> peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least <t>three</t> independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Mca P L A Q A V Dpa R S S S R Nh2 Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mca p l a q a v dpa r s s s r nh2 fluorogenic peptide substrate iii/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mca p l a q a v dpa r s s s r nh2 fluorogenic peptide substrate iii - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    mca plaqav dpa rsssr nh2 fluorogenic peptide substrate iii  (R&D Systems)
    94
    R&D Systems mca plaqav dpa rsssr nh2 fluorogenic peptide substrate iii
    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the <t>fluorogenic</t> peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least <t>three</t> independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Mca Plaqav Dpa Rsssr Nh2 Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mca plaqav dpa rsssr nh2 fluorogenic peptide substrate iii/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mca plaqav dpa rsssr nh2 fluorogenic peptide substrate iii - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    mca pro leu ala gln ala val dpa arg ser ser ser arg nh2 fluorogenic peptide substrate iii  (R&D Systems)
    94
    R&D Systems mca pro leu ala gln ala val dpa arg ser ser ser arg nh2 fluorogenic peptide substrate iii
    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the <t>fluorogenic</t> peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least <t>three</t> independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Mca Pro Leu Ala Gln Ala Val Dpa Arg Ser Ser Ser Arg Nh2 Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mca pro leu ala gln ala val dpa arg ser ser ser arg nh2 fluorogenic peptide substrate iii/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mca pro leu ala gln ala val dpa arg ser ser ser arg nh2 fluorogenic peptide substrate iii - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    mca pro leu ala glnala val dpa arg ser serer arg nh2 fluorogenic peptide substrate iii  (R&D Systems)
    93
    R&D Systems mca pro leu ala glnala val dpa arg ser serer arg nh2 fluorogenic peptide substrate iii
    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the <t>fluorogenic</t> peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least <t>three</t> independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Mca Pro Leu Ala Glnala Val Dpa Arg Ser Serer Arg Nh2 Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mca pro leu ala glnala val dpa arg ser serer arg nh2 fluorogenic peptide substrate iii/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    mca pro leu ala glnala val dpa arg ser serer arg nh2 fluorogenic peptide substrate iii - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    fluorogenic peptide substrate iii mca p l a q a v dpa r s s s r nh2  (R&D Systems)
    94
    R&D Systems fluorogenic peptide substrate iii mca p l a q a v dpa r s s s r nh2
    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the <t>fluorogenic</t> peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least <t>three</t> independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Fluorogenic Peptide Substrate Iii Mca P L A Q A V Dpa R S S S R Nh2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic peptide substrate iii mca p l a q a v dpa r s s s r nh2/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    fluorogenic peptide substrate iii mca p l a q a v dpa r s s s r nh2 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    mca pro leu ala glnala val dpa arg ser ser ser arg nh2 fluorogenic peptide substrate iii  (R&D Systems)
    94
    R&D Systems mca pro leu ala glnala val dpa arg ser ser ser arg nh2 fluorogenic peptide substrate iii
    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the <t>fluorogenic</t> peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least <t>three</t> independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.
    Mca Pro Leu Ala Glnala Val Dpa Arg Ser Ser Ser Arg Nh2 Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mca pro leu ala glnala val dpa arg ser ser ser arg nh2 fluorogenic peptide substrate iii/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mca pro leu ala glnala val dpa arg ser ser ser arg nh2 fluorogenic peptide substrate iii - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the fluorogenic peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least three independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.

    Journal: iScience

    Article Title: 2′-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood

    doi: 10.1016/j.isci.2025.114308

    Figure Lengend Snippet: 2′-FL transactivates EGFR in IECs via stimulating the release of HB-EGF from the cell membrane to bind to EGFR (A and C) Cells were treated with 2′-FL at indicated concentrations or 20 μg/mL of lactose or glucose for 2 h (A), or 2′-FL at 20 μg/mL for 2 h with and without 1-h pretreatment of HB-EGF neutralizing antibody at 500 ng/mL that was present with 2′-FL treatment (C). Total cellular lysates were prepared for Western blot analysis of the phosphorylated and total levels of EGFR and ERK1/2. β-actin blot was used as the protein loading control. (B) Cells were treated with 2′-FL at 20 μg/mL for indicated times. Cell culture supernatants were collected for ELISA analysis of HB-EGF levels. Data are presented as pg of HB-EGF in culture supernatant from 105 cells. (D) YAMC cells were treated with 2′-FL, lactose, or glucose at 20 μg/mL for 2 h. At the end of the treatment, the fluorogenic peptide substrate (4 μM) was added to cell culture medium and incubated for 2 h. The fluorescent intensity in supernatants was measured at 30, 60, 90, and 120 min after reaction. Data are presented as relative fluorescence unit (RFU)/minute in the indicated reaction period from 104 cells. Images in (A) and (C) represent data from at least three independent experiments. In (B) and (D), data were triplicated in each experiment, and the symbol represents the average data from individual experiment. Statistical significance was determined using unpaired t -tests and one-way ANOVA analysis of variance. ∗ p < 0.05 compared to the control group of the same cell line in (B). ∗ p < 0.05 compared to the control, glucose, and lactose groups in the same reaction period in (D). Data are represented as mean ± SD.

    Article Snippet: 0.6 mL of RPMI medium/well containing 4 μM fluorogenic peptide Substrate III (Mca-P-L-A-Q-A-V-Dpa-R-S-S-S-R-NH2, #ES003, R&D Systems) was added to cell cultures.

    Techniques: Membrane, Western Blot, Control, Cell Culture, Enzyme-linked Immunosorbent Assay, Incubation, Fluorescence